Skip to main content
Premium Trial:

Request an Annual Quote

Interpace Dx Regains Compliance With Nasdaq Listing Requirement

NEW YORK (GenomeWeb) – Interpace Diagnostics announced today that it has regained compliance with the Nasdaq's minimum closing bid price requirement, addressing one of two issues facing the company's ability to trade its stock on the exchange.

About a year ago, Interpace received notification that its shares faced being delisted from the Nasdaq for failing  to meet Nasdaq's $1 minimum bid price requirement. To help regain compliance, Interpace effected a 1-for-10 reverse stock split in December, and its shares are now trading around $5.30.

In November, however, Interpace was notified by Nasdaq that its stock faced delisting for the company's failure to maintain a minimum of $2.5 million in stockholders' equity. Interpace said today that it has submitted a plan to the exchange to regain compliance with this requirement.

The Scan

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.

Algorithm Teases Out Genetic Ancestry in Individuals at Biobank Scale

Researchers develop an algorithm known as Rye to tease apart ancestry fractions in admixed individuals at a biobank-scale, applying it to 488,221 UK Biobank participants in Nucleic Acids Research.

Multi-Ancestry Analysis Highlights Comparable Common Variants at Complex Trait-Linked Loci

Researchers in Nature Genetics examine common variants implicated in more than three dozen conditions, estimating genetic effect similarities across ancestry tracts in admixed individuals.

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.